Added to YB: 2023-07-12
Pitch date: 2023-07-12
NUVB [bullish]
Nuvation Bio Inc.
+172.99%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on developing product candidates for cancer treatment.
Market Cap
$1.7B
Pitch Price
$1.74
Price Target
N/A
Dividend
N/A
EV/EBITDA
-11.01
P/E
-11.12
EV/Sales
8.65
Sector
Pharmaceuticals
Category
N/A
Show full summary:
Nuvation Bio NUVB
A summary for this pitch has not been created yet.
Read full article (0 min)